Jim Mervis

Chairman, CoDa Therapeutics. CEO, Engender Technologies

  • Biotech and Life Sciences

Jim Mervis is a catalyst for success in company development in life sciences and communications. He has an extensive background in securities and commercial transactions, defining and establishing strategic alliances and securing the financial and human resources for corporate growth.

During the past eight years, Mr. Mervis played a pivotal role in the structure, finance and management of four of the most notable bio-pharmaceutical start-ups of the period: Barrier Therapeutics, Cardiokine, Intercept Pharmaceuticals and CoDa Therapeutics. Mr. Mervis' current activities are conducted through Bioscience Strategies NZ Ltd.